Your browser doesn't support javascript.
Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies.
Chan, Wei Yee; Zhu, Catherine; Sanchez, Emilie; Gupta, Rajeev; Fielding, Adele K; Khwaja, Asim; Payne, Elspeth M; O'Nions, Jenny.
  • Chan WY; Department of Haematology, University College London NHS Foundation Trust, London, UK.
  • Zhu C; Department of Haematology, University College London NHS Foundation Trust, London, UK.
  • Sanchez E; UCL Cancer Institute, University College London, London, UK.
  • Gupta R; Department of Virology, University College London NHS Foundation Trust, London, UK.
  • Fielding AK; Department of Haematology, University College London NHS Foundation Trust, London, UK.
  • Khwaja A; UCL Cancer Institute, University College London, London, UK.
  • Payne EM; Department of Haematology, University College London NHS Foundation Trust, London, UK.
  • O'Nions J; UCL Cancer Institute, University College London, London, UK.
Br J Haematol ; 198(3): 478-481, 2022 08.
Article in English | MEDLINE | ID: covidwho-1831983
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.18248

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.18248